Cargando…

Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma

BACKGROUND: In the absence of randomized studies directly comparing chimeric antigen receptor T cell therapies, this study used matching-adjusted indirect comparisons (MAIC) to evaluate the comparative efficacy and safety of lisocabtagene maraleucel (liso-cel) versus axicabtagene ciloleucel (axi-cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maloney, David G., Kuruvilla, John, Liu, Fei Fei, Kostic, Ana, Kim, Yeonhee, Bonner, Ashley, Zhang, Yixie, Fox, Christopher P., Cartron, Guillaume
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425084/ https://www.ncbi.nlm.nih.gov/pubmed/34493319 http://dx.doi.org/10.1186/s13045-021-01144-9

Ejemplares similares

Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel
por: Cartron, Guillaume, et al.
Publicado: (2022)

Indirect Treatment Comparison of Liso-Cel vs. Salvage Chemotherapy in Diffuse Large B-Cell Lymphoma: TRANSCEND vs. SCHOLAR-1
por: Salles, Gilles, et al.
Publicado: (2021)

Mar cel Levi
por: Baltesen, Frits
Publicado: (2021)

Pathogenic Carboxyl Ester Lipase (CEL) Variants Interact with the Normal CEL Protein in Pancreatic Cells
por: Dalva, Monica, et al.
Publicado: (2020)

Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
por: Ghione, Paola, et al.
Publicado: (2022)

P1391: VARNIMCABTAGENE AUTOLEUCEL (VAR-CEL) IN RELAPSED/ REFRACTORY CD19+ NON-HODGKIN LYMPHOMA
por: Martinez-Cibrian, Nuria, et al.
Publicado: (2023)

Expression, Characterization and Synergistic Interactions of Myxobacter Sp. AL-1 Cel9 and Cel48 Glycosyl Hydrolases
por: Ramírez-Ramírez, Norma, et al.
Publicado: (2008)

Phase 2 results of idecabtagene vicleucel (ide-cel, bb2121) in Japanese patients with relapsed and refractory multiple myeloma
por: Minakata, Daisuke, et al.
Publicado: (2023)

Cel i terra : l'art dels cartógrafs a la Universitat de Valéncia /
Publicado: (1996)

Accurate In-Vivo Quantification of CD19 CAR-T Cells after Treatment with Axicabtagene Ciloleucel (Axi-Cel) and Tisagenlecleucel (Tisa-Cel) Using Digital PCR
por: Badbaran, Anita, et al.
Publicado: (2020)

P1203: EFFICACY AND SAFETY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) FOR THE TREATMENT OF RELAPSE/REFRACTORY NON-HODGKIN LYMPHOMA: FIRST REAL-WORLD DATA IN CHINESE POPULATION
por: Wang, LI, et al.
Publicado: (2023)

Catalytic Mechanism of Cellulose Degradation by a Cellobiohydrolase, CelS
por: Saharay, Moumita, et al.
Publicado: (2010)

Hypocrea jecorina CEL6A protein engineering
por: Lantz, Suzanne E, et al.
Publicado: (2010)

Regulation of cel Genes of C. cellulolyticum: Identification of GlyR2, a Transcriptional Regulator Regulating cel5D Gene Expression
por: Fendri, Imen, et al.
Publicado: (2013)

Molecular and biochemical characterization of recombinant cel12B, cel8C, and peh28 overexpressed in Escherichia coli and their potential in biofuel production
por: Ibrahim, Eman, et al.
Publicado: (2017)

P1154: EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS AXI-CEL IN R/R DLBCL CAR T-NAIVE AND CAR T-ELIGIBLE PATIENTS: AN INDIRECT COMPARISON
por: Thieblemont, Catherine, et al.
Publicado: (2023)

Molecular Dynamics and Metadynamics Simulations of the Cellulase Cel48F
por: Vital de Oliveira, Osmair
Publicado: (2014)

Alleviating product inhibition in cellulase enzyme Cel7A
por: Atreya, Meera E., et al.
Publicado: (2015)

Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China
por: Ying, Zhitao, et al.
Publicado: (2020)

Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients
por: Sanoyan, Dilara Akhoundova, et al.
Publicado: (2023)

Structure and stability of metagenome-derived glycoside hydrolase family 12 cellulase (LC-CelA) a homolog of Cel12A from Rhodothermus marinus()
por: Okano, Hiroyuki, et al.
Publicado: (2014)

P1710: LISOCABTAGENE MARALEUCEL (LISO-CEL) AS SECOND-LINE TREATMENT FOR R/R LARGE B-CELL LYMPHOMA (LBCL) IN PATIENTS NOT INTENDED FOR HSCT: PATIENT-REPORTED OUTCOMES (PRO) FROM THE PHASE 2 PILOT STUDY
por: Gordon, L. I., et al.
Publicado: (2022)

S220: REAL-WORLD OUTCOMES OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) FOR RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA: A CIBMTR SUBGROUP ANALYSIS BY PRIOR TREATMENT
por: Ahmed, Nausheen, et al.
Publicado: (2023)

Le web cél bre en direct ses 20 ans
Publicado: (2009)

Application of the CardioCel bovine pericardial patch – a preliminary report
por: Sobieraj, Michał, et al.
Publicado: (2016)

Determination of the native features of the exoglucanase Cel48S from Clostridium thermocellum
por: Liu, Ya-Jun, et al.
Publicado: (2018)

Nanoscale dynamics of cellulose digestion by the cellobiohydrolase TrCel7A
por: Haviland, Zachary K., et al.
Publicado: (2021)

Molecular Characterization of Xyloglucanase cel74a from Trichoderma reesei
por: Lopes, Douglas Christian Borges, et al.
Publicado: (2021)

Molecular and Biochemical Analyses of CbCel9A/Cel48A, a Highly Secreted Multi-Modular Cellulase by Caldicellulosiruptor bescii during Growth on Crystalline Cellulose
por: Yi, Zhuolin, et al.
Publicado: (2013)

Le web, maitre du monde, cél bre ses 20 ans
Publicado: (2009)

Structural Insights into the Affinity of Cel7A Carbohydrate-binding Module for Lignin
por: Strobel, Kathryn L., et al.
Publicado: (2015)

CEL-Seq2: sensitive highly-multiplexed single-cell RNA-Seq
por: Hashimshony, Tamar, et al.
Publicado: (2016)

Homologous Expression of the Caldicellulosiruptor bescii CelA Reveals that the Extracellular Protein Is Glycosylated
por: Chung, Daehwan, et al.
Publicado: (2015)

CeL-ID: cell line identification using RNA-seq data
por: Mohammad, Tabrez A., et al.
Publicado: (2019)

Lack of association between the pancreatitis risk allele CEL-HYB and pancreatic cancer
por: Shindo, Koji, et al.
Publicado: (2017)

Interfacial molecular interactions of cellobiohydrolase Cel7A and its variants on cellulose
por: Mudinoor, Akshata R., et al.
Publicado: (2020)

P1454: REAL-WORLD OUTCOMES OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) FOR THE TREATMENT OF RELAPSED OR REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL) IN THE UNITED STATES (US)
por: Locke, F., et al.
Publicado: (2022)

P1197: AXICABTAGENE CILOLEUCEL (AXI-CEL) IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) LARGE B-CELL LYMPHOMA (LBCL): OUTCOMES OF THE PHASE 2 ZUMA-14 STUDY
por: Strati, P., et al.
Publicado: (2022)

Molecular analysis of hyperthermophilic endoglucanase Cel12B from Thermotoga maritima and the properties of its functional residues
por: Shi, Hao, et al.
Publicado: (2014)

P809: BASELINE CHARACTERISTICS IDENTIFYING PATIENTS WITH MULTIPLE MYELOMA TREATED WITH IDECABTAGENE VICELEUCEL (IDE-CEL; BB2121) WHO ARE AT RISK FOR SEVERE/REFRACTORY INFLAMMATORY ADVERSE EVENTS
por: Mashadi-Hossein, Afshin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4l4ultoe3duln4s594kc2aqala